| 头孢哌酮/舒巴坦治疗老年患者下呼吸道感染的疗效与安全性 |
| |
| 引用本文： | 许蕾,王笑歌. 头孢哌酮/舒巴坦治疗老年患者下呼吸道感染的疗效与安全性[J]. 中华医院感染学杂志, 2006, 16(10): 1157-1158 |
| |
| 作者姓名： | 许蕾 王笑歌 |
| |
| 作者单位： | 沈阳中国医科大学附属第四临床医院,辽宁,沈阳,110000 |
| |
| 摘 要： | 目的评价头孢哌酮/舒巴坦治疗老年患者下呼吸道感染的临床疗效及安全性。方法86例明确下呼吸道感染>70岁的老年患者随机分为两组:头孢哌酮/舒巴坦组46例,1.0~2.0 g,静脉滴注2次/d;头孢哌酮组40例,1.0~2.0 g,静脉滴注2次/d,疗程5~14 d作对照。结果试验组和对照组的临床有效率分别为100%和80%,经统计学处理差异有统计学意义(P<0.05),不良反应率分别为4.98%和25.00%,差异有统计学意义(P<0.05)。结论头孢哌酮/舒巴坦适用于治疗老年患者下呼吸道感染性疾病。
|
| 关 键 词： | 头孢哌酮/舒巴坦 头孢哌酮 老年患者下呼吸道感染 |
| 文章编号： | 1005-4529（2006）10-1157-02 |
| 收稿时间： | 2006-01-16 |
| 修稿时间： | 2006-03-22 |
Efficacy and Safety of Cefoperazone/sulbactam in Treatment of Lower Respiratory Tract Infections of Elderly: A Clinical Study Compared with Cefoperazone |
| |
| XU Lei,WANG Xiao-ge. Efficacy and Safety of Cefoperazone/sulbactam in Treatment of Lower Respiratory Tract Infections of Elderly: A Clinical Study Compared with Cefoperazone[J]. Chinese Journal of Nosocomiology, 2006, 16(10): 1157-1158 |
| |
| Authors: | XU Lei WANG Xiao-ge |
| |
| Affiliation: | The Fourth Hospitol, China Medical University, Shenyang, Liaoning 110000, China |
| |
| Abstract: | OBJECTIVE To evaluate the efficacy and safety of cefoperazone/sulbactam in comparison with cefoperazone in(treatment) of lower respiratory tract infections of elderly.METHODS Eighty six patients((>seventy) years old) with lung infections were equally divided into two groups:cefoperazone/sulbactam group and cefoperazone group in a regimen of 1.0-2.0 g,twice daily for 5-14 days.RESULTS The effective rate of both agents were 100% and 80%,and their ADRs incidence rate of elderly was 4.98% and 25.00%, respectively.There were statistically significant difference(P(<0.05)).CONCLUSIONS From results of this study it can be(concluded) that cefoperazone/sulbactam is an effective and safe drug for treatment of lung infection of elderly. |
| |
| Keywords: | Cefoperazone/sulbactam Cefoperazone Lower respiratory tract infection |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
